Search

everythinglearnresearchcommunity

for

Search:↓

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The exact cause of hidradenitis suppurativa is still unknown.

Lower MC2R expression may contribute to alopecia areata.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Hormonal treatments effectively treat acne in females and could reduce antibiotic use.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

The exact cause of hidradenitis suppurativa is unclear, but it may involve hair follicles, hormones, genetics, and smoking.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

Impaired skin barrier function worsens acne.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Keratinocytes contribute to hidradenitis suppurativa by causing inflammation and worsening the condition.

Different γδ T cell types have unique roles in causing alopecia areata.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

A specific gene change is linked to severe hair loss.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

ILC1-like cells can independently cause alopecia areata.

AMT may cause hair loss and changing dWAT activity could help treat it.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Microbial biofilms may cause red scrotum syndrome.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Interleukin-15 can help hair growth and protect hair follicles.